RT @Janetbirdope: Reader beware: Interpretation of relative effectiveness & safety of JAKi vs bDMARDs in real world

Social Author Image
https://pbs.twimg.com/profile_images/1007774150000332801/SjLeJk3G.jpg
Tweet Author
Janetbirdope
Social Author Name
Janet Pope
Tweet Content
Reader beware: Interpretation of relative effectiveness & safety of JAKi vs bDMARDs in real world data POS0093 JAK-pot heterogeneity between countries with variable safety @RheumNow @eular_org #EULAR2021 19 registries >700 JAK RA Rx markedly diff d/c due to AEs https://t.co/jFgN8NVx8v
Show on Archive Page
On
Display in Search Results
On
PDQ
Off

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×